GPV becomes part of the European Innovation Council

GPV becomes part of the European Innovation Council

  Great Product Ventures is very pleased to announce that it has been selected to become part of the European Commission's EU Innovation Council for the EIC Ecosystem Partnership and Co-investment Program. The European Innovation Council ( EIC ) has been...

Great Product Ventures new offices @MIND

Great Product Ventures new offices @MIND

Great Product Ventures, Inc. Announces the opening of its European headquarters at MIND, Milano Innovation District, to strenghten its mission of supporting EU companies internationalization in the US market Cambridge, MA, United States and Milano, Italy, December...

AEBiosystems S.r.l. and Great Product Ventures Inc.

AEBiosystems S.r.l. and Great Product Ventures Inc.

AEBiosystems S.r.l. and Great Product Ventures, Inc. Announce a Joint Venture to Bring a Suite of Hi-Tech Patches to Remotely Monitor Vital Health Parameters to North America. Cambridge, MA, United States and Rome, Italy October 2022 /EIN Newswire/— Advanced...

FRM S.r.l and Great Product Ventures Inc.

FRM S.r.l and Great Product Ventures Inc.

FRM S.r.l., and Great Product Ventures, Inc. announce a Strategic Partnership to Bring to the US market a modular, affordable, and sustainable technology for vertical farming of bio-fortified plants for personalized nutrition Cambridge, MA, United States and Rovereto,...

TO.TEM S.r.l and Great Product Ventures Inc.

TO.TEM S.r.l and Great Product Ventures Inc.

TO.TEM S.r.l., spin-off of Punch Torino S.p.A., and Great Product Ventures, Inc. announce a Strategic Partnership to Bring to the US market italian designed, high-tech solutions for green micromobility Cambridge, MA, United States and Turin, Italy, TO.TEM S.r.l., a...

Bio4Dreams S.p.A and Great Product Ventures Inc.

Bio4Dreams S.p.A and Great Product Ventures Inc.

Bio4Dreams S.p.A. and Great Product Ventures, Inc. Announce a Strategic Partnership to Bring to the US market an outstanding portfolio of innovative companies in the Life Sciences space Cambridge, MA, United States and Milan, Italy, September 21 st , 2022 /EIN...

MED-TECH

CONSUMER PRODUCTS

SMART CITIES

GREEN-TECH

Creating value through commercialization

Analyse

01

The market of the idea, the technology, the IP, the funding needs and the maturirty stage, to evaluate potential and US market fit.

Build

02

A personalized partnership proposal, based on a Business Plan with sales targets and all the activities needed to go to market, from a regulatory, IP management, business development and fundraising standpoint.

Realize value

03

The Business Plan, setting up a US legal entity with agreed equity split + governance, location @GP’s premises and GP’s partners as operative resources.

Benefits

  • A US entity of which you own XX% and have shared board control
  • GP Partners working for you in the US
  • Office location @GP’ premises in Cambridge, MA and/or Miami, FL
  • Cash raised does not touch or dilute your cap table in the EU
  • Significant economic impact on your EU company: higher valuations, more funds raised, boost your EU business because the US entity becomes a client.

Billion funded for EU firms in the US

Mergers & acquisitions

Patents granted

FDA approvals

Our focus:

Commercialization

The true success of a company is revenue generation through commercialization. Our team is made up of senior executives who are all successful entrepreneurs in the medical, biotech and pharma sectors, with product launches that have resulted in over $500 million in sales.

With this objective in mind, we “reverse engineer” everything needed to achieve your commercial success in the US:
• Regulatory & FDA Approvals
• IP management
• Funding
• Business development
• Marketing & Sales
• Manufacturing

Our retail distribution team has historically sold

over $500,000,000 of product into these retailers:

Great Product has established ”C” level relationships with key commercial organizations operating in the US and global markets.

This combination allows us to uniquely offer our clients unique value multipliers for funding and commercialization.